List of Tables
Table 1. Global Tumor Necrosis Factor Inhibitors Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tumor Necrosis Factor Inhibitors Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Tumor Necrosis Factor Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) of Key Manufacturers (2020-2025)
Table 5. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tumor Necrosis Factor Inhibitors Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tumor Necrosis Factor Inhibitors Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tumor Necrosis Factor Inhibitors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tumor Necrosis Factor Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tumor Necrosis Factor Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Tumor Necrosis Factor Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tumor Necrosis Factor Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Necrosis Factor Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tumor Necrosis Factor Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tumor Necrosis Factor Inhibitors Sales by Region (2020-2025) & (K Pcs)
Table 18. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Region (2020-2025)
Table 19. Global Tumor Necrosis Factor Inhibitors Sales by Region (2026-2031) & (K Pcs)
Table 20. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Region (2026-2031)
Table 21. Global Tumor Necrosis Factor Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Region (2020-2025)
Table 23. Global Tumor Necrosis Factor Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Region (2026-2031)
Table 25. North America Tumor Necrosis Factor Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tumor Necrosis Factor Inhibitors Sales by Country (2020-2025) & (K Pcs)
Table 27. North America Tumor Necrosis Factor Inhibitors Sales by Country (2026-2031) & (K Pcs)
Table 28. North America Tumor Necrosis Factor Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tumor Necrosis Factor Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tumor Necrosis Factor Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tumor Necrosis Factor Inhibitors Sales by Country (2020-2025) & (K Pcs)
Table 32. Europe Tumor Necrosis Factor Inhibitors Sales by Country (2026-2031) & (K Pcs)
Table 33. Europe Tumor Necrosis Factor Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tumor Necrosis Factor Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tumor Necrosis Factor Inhibitors Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tumor Necrosis Factor Inhibitors Sales by Region (2020-2025) & (K Pcs)
Table 37. Asia Pacific Tumor Necrosis Factor Inhibitors Sales by Region (2026-2031) & (K Pcs)
Table 38. Asia Pacific Tumor Necrosis Factor Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tumor Necrosis Factor Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tumor Necrosis Factor Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tumor Necrosis Factor Inhibitors Sales by Country (2020-2025) & (K Pcs)
Table 42. Latin America Tumor Necrosis Factor Inhibitors Sales by Country (2026-2031) & (K Pcs)
Table 43. Latin America Tumor Necrosis Factor Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tumor Necrosis Factor Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tumor Necrosis Factor Inhibitors Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tumor Necrosis Factor Inhibitors Sales by Country (2020-2025) & (K Pcs)
Table 47. Middle East and Africa Tumor Necrosis Factor Inhibitors Sales by Country (2026-2031) & (K Pcs)
Table 48. Middle East and Africa Tumor Necrosis Factor Inhibitors Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tumor Necrosis Factor Inhibitors Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Type (2020-2025)
Table 51. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Type (2026-2031)
Table 52. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2020-2025)
Table 53. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Type (2026-2031)
Table 54. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Type (2020-2025)
Table 57. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Type (2026-2031)
Table 58. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Type (2020-2025)
Table 59. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Type (2026-2031)
Table 60. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Application (2020-2025)
Table 61. Global Tumor Necrosis Factor Inhibitors Sales (K Pcs) by Application (2026-2031)
Table 62. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2020-2025)
Table 63. Global Tumor Necrosis Factor Inhibitors Sales Market Share by Application (2026-2031)
Table 64. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Tumor Necrosis Factor Inhibitors Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Application (2020-2025)
Table 67. Global Tumor Necrosis Factor Inhibitors Revenue Market Share by Application (2026-2031)
Table 68. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Application (2020-2025)
Table 69. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Application (2026-2031)
Table 70. EPIRUS Biopharmaceuticals Company Information
Table 71. EPIRUS Biopharmaceuticals Description and Business Overview
Table 72. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 73. EPIRUS Biopharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 74. EPIRUS Biopharmaceuticals Recent Developments/Updates
Table 75. Bionovis Company Information
Table 76. Bionovis Description and Business Overview
Table 77. Bionovis Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 78. Bionovis Tumor Necrosis Factor Inhibitors Product
Table 79. Bionovis Recent Developments/Updates
Table 80. CASI Pharmaceuticals Company Information
Table 81. CASI Pharmaceuticals Description and Business Overview
Table 82. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 83. CASI Pharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 84. CASI Pharmaceuticals Recent Developments/Updates
Table 85. Janssen Biotech Company Information
Table 86. Janssen Biotech Description and Business Overview
Table 87. Janssen Biotech Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 88. Janssen Biotech Tumor Necrosis Factor Inhibitors Product
Table 89. Janssen Biotech Recent Developments/Updates
Table 90. Momenta Pharmaceuticals Company Information
Table 91. Momenta Pharmaceuticals Description and Business Overview
Table 92. Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 93. Momenta Pharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 94. Momenta Pharmaceuticals Recent Developments/Updates
Table 95. GlaxoSmithKline Company Information
Table 96. GlaxoSmithKline Description and Business Overview
Table 97. GlaxoSmithKline Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Tumor Necrosis Factor Inhibitors Product
Table 99. GlaxoSmithKline Recent Developments/Updates
Table 100. HanAll Biopharma Company Information
Table 101. HanAll Biopharma Description and Business Overview
Table 102. HanAll Biopharma Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 103. HanAll Biopharma Tumor Necrosis Factor Inhibitors Product
Table 104. HanAll Biopharma Recent Developments/Updates
Table 105. Intas Pharmaceuticals Company Information
Table 106. Intas Pharmaceuticals Description and Business Overview
Table 107. Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 108. Intas Pharmaceuticals Tumor Necrosis Factor Inhibitors Product
Table 109. Intas Pharmaceuticals Recent Developments/Updates
Table 110. LEO Pharma Company Information
Table 111. LEO Pharma Description and Business Overview
Table 112. LEO Pharma Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 113. LEO Pharma Tumor Necrosis Factor Inhibitors Product
Table 114. LEO Pharma Recent Developments/Updates
Table 115. Dexa Medica Company Information
Table 116. Dexa Medica Description and Business Overview
Table 117. Dexa Medica Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 118. Dexa Medica Tumor Necrosis Factor Inhibitors Product
Table 119. Dexa Medica Recent Developments/Updates
Table 120. LG Life Sciences Company Information
Table 121. LG Life Sciences Description and Business Overview
Table 122. LG Life Sciences Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 123. LG Life Sciences Tumor Necrosis Factor Inhibitors Product
Table 124. LG Life Sciences Recent Developments/Updates
Table 125. MedImmune Company Information
Table 126. MedImmune Description and Business Overview
Table 127. MedImmune Tumor Necrosis Factor Inhibitors Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 128. MedImmune Tumor Necrosis Factor Inhibitors Product
Table 129. MedImmune Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Tumor Necrosis Factor Inhibitors Distributors List
Table 133. Tumor Necrosis Factor Inhibitors Customers List
Table 134. Tumor Necrosis Factor Inhibitors Market Trends
Table 135. Tumor Necrosis Factor Inhibitors Market Drivers
Table 136. Tumor Necrosis Factor Inhibitors Market Challenges
Table 137. Tumor Necrosis Factor Inhibitors Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tumor Necrosis Factor Inhibitors
Figure 2. Global Tumor Necrosis Factor Inhibitors Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tumor Necrosis Factor Inhibitors Market Share by Type: 2024 & 2031
Figure 4. Humira Product Picture
Figure 5. Enbrel Product Picture
Figure 6. Remicade Product Picture
Figure 7. Others Product Picture
Figure 8. Global Tumor Necrosis Factor Inhibitors Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Tumor Necrosis Factor Inhibitors Market Share by Application: 2024 & 2031
Figure 10. Alzheimer's Diseases
Figure 11. Parkinson's Diseases
Figure 12. Ischemic Stroke
Figure 13. Multiple Sclerosis
Figure 14. Others
Figure 15. Global Tumor Necrosis Factor Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Tumor Necrosis Factor Inhibitors Market Size (2020-2031) & (US$ Million)
Figure 17. Global Tumor Necrosis Factor Inhibitors Sales (2020-2031) & (K Pcs)
Figure 18. Global Tumor Necrosis Factor Inhibitors Average Price (USD/Pcs) & (2020-2031)
Figure 19. Tumor Necrosis Factor Inhibitors Report Years Considered
Figure 20. Tumor Necrosis Factor Inhibitors Sales Share by Manufacturers in 2024
Figure 21. Global Tumor Necrosis Factor Inhibitors Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Tumor Necrosis Factor Inhibitors Players: Market Share by Revenue in Tumor Necrosis Factor Inhibitors in 2024
Figure 23. Tumor Necrosis Factor Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Tumor Necrosis Factor Inhibitors Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Tumor Necrosis Factor Inhibitors Sales Market Share by Country (2020-2031)
Figure 26. North America Tumor Necrosis Factor Inhibitors Revenue Market Share by Country (2020-2031)
Figure 27. U.S. Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Tumor Necrosis Factor Inhibitors Sales Market Share by Country (2020-2031)
Figure 30. Europe Tumor Necrosis Factor Inhibitors Revenue Market Share by Country (2020-2031)
Figure 31. Germany Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Tumor Necrosis Factor Inhibitors Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Tumor Necrosis Factor Inhibitors Revenue Market Share by Region (2020-2031)
Figure 38. China Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Taiwan Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Indonesia Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Thailand Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Malaysia Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Philippines Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Tumor Necrosis Factor Inhibitors Sales Market Share by Country (2020-2031)
Figure 49. Latin America Tumor Necrosis Factor Inhibitors Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Tumor Necrosis Factor Inhibitors Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Tumor Necrosis Factor Inhibitors Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Tumor Necrosis Factor Inhibitors Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Tumor Necrosis Factor Inhibitors by Type (2020-2031)
Figure 59. Global Revenue Market Share of Tumor Necrosis Factor Inhibitors by Type (2020-2031)
Figure 60. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Type (2020-2031)
Figure 61. Global Sales Market Share of Tumor Necrosis Factor Inhibitors by Application (2020-2031)
Figure 62. Global Revenue Market Share of Tumor Necrosis Factor Inhibitors by Application (2020-2031)
Figure 63. Global Tumor Necrosis Factor Inhibitors Price (USD/Pcs) by Application (2020-2031)
Figure 64. Tumor Necrosis Factor Inhibitors Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
